Orgenesis Inc. Downgraded to Pink Limited Tier Due to Delinquent Filing of 10-K Report
Orgenesis Inc. has been downgraded from the OTCQX tier to the Pink Limited tier on the OTC Markets due to its failure to file the required 10-K report for the period ending December 31, 2024. The downgrade will take effect on June 3, 2025, following the company's inability to rectify this issue within the 45-day cure period provided by the OTCQX Rules.
Orgenesis Inc. has announced a regulatory issue concerning its listing status on the OTC Markets. On June 2, 2025, the OTC Markets Group informed the company that its common stock would be moved from the OTCQX tier to the Pink Limited tier, effective June 3, 2025. This decision follows Orgenesis Inc.’s failure to file its 10-K report for the period ending December 31, 2024, which is a requirement for continued qualification under the OTCQX Rules. The company did not address this deficiency within the 45-day cure period allowed. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Orgenesis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001641172-25-014075), on June 06, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here
